We learned a lot about salvage therapy a few days back.   Let’s continue our multiple myeloma education and study the ABCs of therapy for newly diagnosed patients.

A few days back I ran a post about how improvements in the way allogeneic transplants are administered may help reduce the number and severity of side-effects:

One year ago, I wrote several articles about NBA Orlando Magic executive Pat Williams, and his unexpected multiple myeloma diagnosis:

Amyloidosis is a close cousin to multiple myeloma.

Last month I was featured in a Nature Magazine article about multiple myeloma and stem cell transplants:

For every comment that shows-up on my site, I receive at least three or four emails.  Apparently, so does our new nutritional columnist, Danny Parker.

I’m heading-off to Moffitt Cancer Center first thing this am to meet with my myeloma specialist, Dr. Melissa Alsina.

Did you happen to read this article in The Myeloma Beacon Monday:

For those of you who haven’t visited this site recently, you are in for a surprise!

I have been struggling with starting a systematic review of my recent post-transplant set-back.

For those of you who didn’t see this, I wanted to share these excerpts from a Cure Magazine/Reuters article about timing a stem cell transplant:

Some have wondered where the pictures of my lovely wife, Pattie, were from our trip last week.

I have been writing a lot about stem cell transplants lately, having recently lived through the experience myself.

Before I begin, I have a request for my fellow stem cell transplant survivors:  Please hold your critical comments and emails, unless your are so upset you feel you must say something.  In that case, please be kind…

Thanks again for all of the encouraging emails and for sharing your personal transplant stories.  I really appreciate it!

I think it is understandable I have been featuring a lot of stem cell transplant (SCT) related news and info lately.  So has the Myeloma Beacon.

I was interested to learn how my myeloma specialist, Dr. Melissa Alsina, was working closely with officials in Puerto Rico to develop a comprehensive bone marrow/stem cell transplant program.

OK, OK.  I know I was a bit negative late yesterday afternoon after posting what I felt were far from impressive, post stem cell transplant (SCT) news and numbers researchers have found using Revlimid as a maintenance drug.

Last week was a week my body would like to forget.  After concluding 13 radiation therapy sessions–focused on a new myeloma lesion in my right hip–I began my pre-stem cell transplant induction.

Pattie and I shared a wonderful day together today.  As I wrote this morning, we were celebrating the fourth anniversary of my original multiple myeloma diagnosis.  I’m still alive and kicking–now that’s something to celebrate!